» Articles » PMID: 29789596

Cervical Vagus Nerve Morphometry and Vascularity in the Context of Nerve Stimulation - A Cadaveric Study

Overview
Journal Sci Rep
Specialty Science
Date 2018 May 24
PMID 29789596
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Vagus nerve stimulation (VNS) has become a well-established therapy for epilepsy and depression, and is emerging to treat inflammatory disease, with the cervical vagus nerve (CVN) as major stimulation site. CVN morphometries are missing for VNS, considering its variability. Morphometric data were obtained from CVNs in 27 cadavers, including branching patterns and histology. Cross-sectional area, greater and lesser diameters averaged 7.2 ± 3.1 mm, 5.1 ± 1.5 and 4.1 ± 1.3 mm, and were ≤11.0 mm, ≤7.0 and ≤5.8 mm in 90% of the specimens, respectively. Midline distance (position lateral to the laryngeal eminence) and skin distance (anterior-posterior from skin) averaged 34.5 ± 6.2 and 36.2 ± 9.4 mm, ≤49.0 and ≤41.0 mm in 90%, respectively. Nerve dimensions and surface topography correlated closely, but without gender-, side- or branching-dependent differences. The nerve fascicle number averaged 5.2 ± 3.5. Vagal arteries were observed in 49% of the cases. Negative correlations were found for age and cross-sectional area, as well as subperineural vessel count. Detailed anatomical data on the CVN and its vascularity are given, forming the morphometric basis for VNS refinement, filling an evident gap in light of the CVN being a structure with variable positions and branching. A 35 × 35-mm rule may apply for the CVN position, irrespective of branching or positional variation.

Citing Articles

Laterality, sexual dimorphism, and human vagal projectome heterogeneity shape neuromodulation to vagus nerve stimulation.

Biscola N, Bartmeyer P, Beshay Y, Stern E, Mihaylov P, Powley T Commun Biol. 2024; 7(1):1536.

PMID: 39562711 PMC: 11576867. DOI: 10.1038/s42003-024-07222-1.


Vagus nerve stimulation for stroke rehabilitation: Neural substrates, neuromodulatory effects and therapeutic implications.

Schambra H, Hays S J Physiol. 2024; 603(3):723-735.

PMID: 39243394 PMC: 11785503. DOI: 10.1113/JP285566.


Vagus nerve stimulation in cerebral stroke: biological mechanisms, therapeutic modalities, clinical applications, and future directions.

Du L, He X, Xiong X, Zhang X, Jian Z, Yang Z Neural Regen Res. 2023; 19(8):1707-1717.

PMID: 38103236 PMC: 10960277. DOI: 10.4103/1673-5374.389365.


Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.

Douglas Bremner J, Gazi A, Lambert T, Nawar A, Harrison A, Welsh J Ann Depress Anxiety. 2023; 10(1).

PMID: 38074313 PMC: 10699253.


Impact of transcutaneous vagus nerve stimulation on healthy cognitive and brain aging.

Trifilio E, Shortell D, Olshan S, ONeal A, Coyne J, Lamb D Front Neurosci. 2023; 17:1184051.

PMID: 37575296 PMC: 10416636. DOI: 10.3389/fnins.2023.1184051.


References
1.
Kawashima T . The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl). 2005; 209(6):425-38. DOI: 10.1007/s00429-005-0462-1. View

2.
Chambers A, Bowen J . Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis. Ont Health Technol Assess Ser. 2013; 13(18):1-37. PMC: 3817921. View

3.
Randich A, Gebhart G . Vagal afferent modulation of nociception. Brain Res Brain Res Rev. 1992; 17(2):77-99. DOI: 10.1016/0165-0173(92)90009-b. View

4.
Gerson R, Murray E, Price B, Frankel M, Douglass L, Cunningham M . Mania following vagus nerve stimulation: a case report and review of the literature. Epilepsy Behav. 2010; 20(1):138-40. DOI: 10.1016/j.yebeh.2010.11.005. View

5.
Goverse G, Stakenborg M, Matteoli G . The intestinal cholinergic anti-inflammatory pathway. J Physiol. 2016; 594(20):5771-5780. PMC: 5063935. DOI: 10.1113/JP271537. View